Phase II and pharmacogenomics study of enzastaurin plus temozolomide during and following radiation therapy in patients with newly diagnosed glioblastoma multiforme and gliosarcoma

Nicholas Butowski, Susan M. Chang, Kathleen R. Lamborn, Mei Yin Polley, Russell Pieper, Joseph F. Costello, Scott Vandenberg, Rupa Parvataneni, Angelina Nicole, Patricia K. Sneed, Jennifer Clarke, Emily Hsieh, Bruno M. Costa, Rui M. Reis, Maria Hristova-Kazmierski, Steven J. Nicol, Donald E. Thornton, Michael D. Prados

Research output: Contribution to journal › Article › peer-review

50 Scopus citations

Fingerprint

Dive into the research topics of 'Phase II and pharmacogenomics study of enzastaurin plus temozolomide during and following radiation therapy in patients with newly diagnosed glioblastoma multiforme and gliosarcoma'. Together they form a unique fingerprint.

Medicine & Life Sciences